CD274 and squamous cell lung carcinoma: In the recent study, PD-L1–vInt4, a splicing variant of PD-L1, was reported to be detectable in clinical samples of lung squamous cell carcinoma (LUSC) and its secretion resisted anti–PD-L1 antibody treatment via alternative polyadenylation.